CureVac sues Moderna for patent infringement over COVID-19 vaccines
By Blake Brittain April 24 (Reuters) - German biotech company CureVac sued Moderna in Delaware feder...
24th April, 2026
By Blake Brittain April 24 (Reuters) - German biotech company CureVac sued Moderna in Delaware feder...
24th April, 2026

FRANKFURT, April 7 - Evotec said on Tuesday it would continue a dialogue with investor MAK Capital,...
7th April, 2026
March 2 (Reuters) - UniQure said on Monday the U.S. health regulator has informed the company that d...
2nd March, 2026
By Bhanvi Satija Feb 27 (Reuters) - Europe's medicines regulator recommended approval for Moderna's...
27th February, 2026
Feb 26 (Reuters) - Eli Lilly on Thursday released new data from a head-to-head trial of its experime...
26th February, 2026
Feb 25 (Reuters) - Danish drugmaker Novo Nordisk has partnered with U.S.-based Vivtex Corp in a deal...
25th February, 2026
Feb 25 (Reuters) - Private equity group EQT said on Wednesday it had decided not to proceed with a t...
25th February, 2026
Feb 25 (Reuters) - Novartis said on Wednesday it intends to build a radioligand therapy manufacturin...
25th February, 2026
Feb 25 (Reuters) - GSK on Wednesday agreed to pay $950 million in cash for Canadian biopharmaceutica...
25th February, 2026

By Maggie Fick LONDON, Feb 24 (Reuters) - Barclays analysts on Tuesday slashed their peak sales fore...
24th February, 2026
Feb 23 (Reuters) - Novo Nordisk's next-generation weight-loss drug CagriSema was less effective than...
23rd February, 2026
COPENHAGEN, Feb 23 (Reuters) - Novo Nordisk said on Monday its experimental obesity drug CagriSema d...
23rd February, 2026